Monoferric denied as not medically necessary by Aetna?
Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Adults with IDA intolerant of or unresponsive to oral iron. Up to 20 mg/kg single dose (max 1000 mg).
What works in the appeal
Monoferric FDA-approved Jan 16, 2020 — NOT experimental. Pivotal FERWON-IDA / FERWON-NEPHRO (Auerbach Am J Hematol 2019). On-label single-dose 1000 mg in one sitting reduces visits, infusion chair time, nursing time vs Venofer (5-10 visits to replete 1g). Total cost of care favors single-dose for working-age and low-access patients.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →